Liquidia (LQDA): Return on Sales by Net Profit

Corporate emblem and logo of Liquidia Technologies (LQDA)

Liquidia Corporation (LQDA) cash flows are unstable due to patent litigation. High dependence on external manufacturers impacts the realization margin ratio, which the GURU.Markets platform captures in this chart; the parameter has stabilized at -15.20. Business prospects rely on the launch of Yutrepia and the development of unique drug delivery systems.

Liquidia Inc. (LQDA) - Company Sales Margin from 07/04/2022 to 11/20/2026

Summary analytical data breakdowns for Liquidia Technologies (LQDA)

- market value and analyst target forecast:
- stock exchange capitalization data:
Initial company analysis:Liquidia, LQDA
Flagship merchandise of Liquidia Corp

Demand for Liquidia Corporation (LQDA) specialized drugs is inelastic; therefore, the core operating net margin reflects operational cost management efficiency rather than market conditions. This indicator measures the portion of net profit in every dollar of revenue, where stable values confirm the business model's resilience to costs, while a sharp decline signals a risk of capital impairment.

Who Liquidia Corporation competes with

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin veronapharma.com|Net Return on Sales MENS (Jyong Biotech Corp)|Net Margin Ligand (LGND)|Net Sales Margin amneal.com (AMRX)|Net Sales Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Net Margin|Galapagos N.V. - Net Sales Margin|ANIP - Net Sales Margin|MNKD: Net Sales Margin|amphastar.com (AMPH) - Net Sales Margin|PCRX (Pacira Pharmaceuticals) - Net Sales Margin|Return on Sales by Net Profit ARS Pharmaceuticals, Inc. (SPRY)|Net Sales Margin TBPH|AQST (Aquestive Therapeutics) - Net Profit Rate|scPharmaceuticals, Inc. - Return on Sales by Net Profit|Net Profit Rate TECX|tonixpharma.com - Net Sales Margin|Net Profit Rate SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Net Margin|Return on Sales by Net Profit BioHarvest|Return on Sales by Net Profit EXOZ|Return on Sales by Net Profit Oramed Pharmaceuticals (ORMP)|Return on Sales by Net Profit ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Net Return on Sales|Net Sales Margin ABVC (ABVC BioPharma Inc)|CPIX - Return on Sales by Net Profit|Quantum BioPharma Corp - Net Sales Margin|FGEN (fibrogen.com) - Net Return on Sales|TELO (Telomir Pharmaceuticals) - Return on Sales by Net Profit|Rani Therapeutics Holdings - Net Profit Rate|Return on Sales by Net Profit SNYR|Net Margin rallybio.com RLYB|Net Sales Margin LEXX|PULM (Pulmatrix, Inc.) - Net Profit Rate|Pheton Holdings - Return on Sales by Net Profit|Net Sales Margin Aptorum Group Limited APM|LYRA: Return on Sales by Net Profit|IBO: Net Margin|TNFA: Net Sales Margin|YCBD: Company Net Profitability|Net Margin PainReform Ltd|CYTO (altamiratherapeutics.com) - Company Net Profitability|Net Sales Margin LIPO|OPTN - Net Margin|Net Margin pieris.com PIRS|Net Profit Rate PROC|PTPI - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma